Markets:

Overview

News

Currencies

International

Treasuries

Danaher Corp (NY:DHR)

186.72 -3.38 (-1.78%)

Streaming Delayed Price Updated: 2:40 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

28 29 Next >

What the Options Market Tells Us About Danaher ↗

November 20, 2024

Via Benzinga

What the Options Market Tells Us About Danaher ↗

November 15, 2024

Via Benzinga

Peering Into Danaher's Recent Short Interest ↗

November 04, 2024

Via Benzinga

Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools & Services Industry ↗

November 04, 2024

Via Benzinga

A Look Into Danaher Inc's Price Over Earnings ↗

November 01, 2024

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today ↗

October 28, 2024

Via Benzinga

Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks. ↗

October 26, 2024

These seven companies are transforming steady profits into rising passive income streams for investors.

Via The Motley Fool

Critical Insights From Danaher Analyst Ratings: What You Need To Know ↗

October 23, 2024

Via Benzinga

A Closer Look at Danaher's Options Market Dynamics ↗

October 22, 2024

Via Benzinga

Earnings Preview: Danaher ↗

October 21, 2024

Via Benzinga

Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating ↗

October 22, 2024

Danaher posts Q3 sales of $5.79 billion, surpassing expectations. 2024 guidance includes bioprocessing revenue decline and Cepheid respiratory sales of $1.7 billion.

Via Benzinga

Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday? ↗

October 22, 2024

Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election just two weeks away. Concerns over U.S. fiscal policies and...

Via Benzinga

Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance ↗

October 22, 2024

Danaher posted third-quarter sales of $5.8 billion, surpassing expectations, with growth in life sciences and diagnostics segments, and a 27.5% operating margin.

Via Benzinga

This Is What Whales Are Betting On Danaher ↗

October 16, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗

October 14, 2024

Via Benzinga

Looking Into Danaher's Recent Short Interest ↗

October 04, 2024

Via Benzinga

Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having 'Significant Upside Potential' ↗

October 18, 2024

Hedge fund manager Daniel Loeb is optimistic about the economy and market and he sees Trump likely retaking White House.

Via Benzinga

Topics Economy Government

Uncovering Noteworthy Technical Analysis Findings for DANAHER CORP (NYSE:DHR). ↗

October 16, 2024

The technical analysis for DANAHER CORP (NYSE:DHR) is highly positive, with a rating of 8 out of 10, suggesting a potential breakout.

Via Chartmill

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. ↗

October 03, 2024

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Via Investor's Business Daily

Topics Stocks

Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst ↗

October 01, 2024

Stifel analyst Jacob Johnson says Danaher is poised for a gradual recovery in 2025 and could generate high-single-digit growth.

Via Benzinga

DANAHER CORP (NYSE:DHR) can be considered a quality stock. Here's why. ↗

October 01, 2024

Why Quality Investors May Find DANAHER CORP (NYSE:DHR) Attractive.

Via Chartmill

$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today ↗

September 27, 2024

Via Benzinga

Spotlight on Danaher: Analyzing the Surge in Options Activity ↗

September 26, 2024

Via Benzinga

Danaher Unusual Options Activity ↗

September 23, 2024

Via Benzinga

Momentum Investing Gives You An Edge, Until It Doesn’t ↗

September 17, 2024

Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system.

Via Talk Markets

Unpacking the Latest Options Trading Trends in Danaher ↗

September 09, 2024

Via Benzinga

$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today ↗

September 06, 2024

Via Benzinga

Smart Money Is Betting Big In DHR Options ↗

September 05, 2024

Via Benzinga

Agilent Technologies Thrives From the Forever Chemicals Crackdown

September 05, 2024

Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets.

Via MarketBeat

$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today ↗

August 26, 2024

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.